As Mothers, you will do anything for your child. Even way before they are brought into this world, your instincts kick in and you tirelessly worry about your baby. You want to learn everything there is to learn and more importantly you want to protect them from anything and everything that can harm them be it in the common cold or a fever; and if you had your way, you would gladly get sick for your child. And your anxiety is not without reason, since there are many childhood diseases that can be harmful or even fatal to children.
Leukemia is perhaps the most common type of cancer compromising 47.8% of all childhood cancers. Hodgkin's Disease or non-Hodgkin Lymphoma is the third childhood cancer comprising 9% of childhood cancer. Aside from these types of cancers, certain brain disorders are also common in children. These includes cerebral palsy and neuroblastoma. Cerebral palsy severely impairs the development of the motor functions and afflicts 1-2 percent of the Philippine population. Neuroblastoma, on the other hand, causes the sufferer to lose the ability to empty the bladder, experience paralysis of the hips, feet, legs and uncontrolled movements.
Research into the use of cord blood and cord lining stem cells have been ongoing since the 1980s and has shown promise of saving lives and treating life-threatening diseases. More than 30,000 cord blood stem cell transplants have already been performed since 1988.
"The strides made in cord blood transplantation has made this manner of treating diseases more widely accepted by people" said Dr. Arvin Fauno, Cordlife Philippines Medical Director. " Currently, umbilical cord blood transplant is considered as one of the standard forms of treatments for leukemia, among others. Also, many clinic trials worldwide are ongoing for which the results are encouraging. In fact, Duke Medicine is studying the use of umbilical cord blood stem cells" to treat autism and related brain disorders. While the trials are still in the initial phases, we are hopeful that these will yield positive results."
Last June, Duke Medicine received USD 15 million funding by Atlanta-based Marcus Foundation. Apart from treating patients based in the United States, Duke Medicine has also opened its door for possible participants from outside of the country provided they meet the inclusion and exclusion criteria to be considered , patients must be aged between 24 months and 72 months old. The patient would also need to travel at least three times to Duke Medicine in the United States - at the infusion, the six- and 12-month follow up stages. A stipend worth US$1000 will likewise be provided to the trial participant per trip to help defray travel expenses.
When popular reporter, Nina Corpuz, decided to bank with Cordlife, she knew it was an investment in her baby's long term health and well-being was the primary reason for her to consider banking her baby's cord blood and cord lining.
Today, Cordlife has served over 3,000 families in the Philippines alone and is trusted by 100,000 parents worldwide.
"We are definitely seeing a growing acceptance and openness of the Filipino market to the idea of the umbilical cord lining and cord blood banking because I believe that the parents are now more proactive in finding better means to complete their family's health protection plan", said Michael Arnonobal, Cordlife Philippines Managing Director. "More importantly, today's mothers see investing in their children and families as paramount to ensuring their legacy and their well-being.
For more info, download Cordlife's free infopack @ www.cordlife.ph or call (02) 3321888 to know you can invest in your children's future.